Related references
Note: Only part of the references are listed.Histone Chaperone CHAF1A Inhibits Differentiation and Promotes Aggressive Neuroblastoma
Eveline Barbieri et al.
CANCER RESEARCH (2014)
Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study
Gemma Gatta et al.
LANCET ONCOLOGY (2014)
TRANSITIONING FROM GENOTYPES TO EPIGENOTYPES: WHY THE TIME HAS COME FOR MEDULLOBLASTOMA EPIGENOMICS
N. V. Batora et al.
NEUROSCIENCE (2014)
EZH2 as a potential target in cancer therapy
Michael T. McCabe et al.
EPIGENOMICS (2014)
Insights into neural crest development and evolution from genomic analysis
Marcos Simoes-Costa et al.
GENOME RESEARCH (2013)
Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
Susan G. Kreissman et al.
LANCET ONCOLOGY (2013)
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
Mark Sausen et al.
NATURE GENETICS (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Resolved and open issues in chromaffin cell development
Klaus Unsicker et al.
MECHANISMS OF DEVELOPMENT (2013)
Long-term Follow-up of the Wait and See Approach to Localized Perinatal Adrenal Neuroblastoma
Denis Andrew Cozzi et al.
WORLD JOURNAL OF SURGERY (2013)
Distinct Neuroblastoma-associated Alterations of PHOX2B Impair Sympathetic Neuronal Differentiation in Zebrafish Models
Desheng Pei et al.
PLOS GENETICS (2013)
A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants A Children's Oncology Group Study
Jed G. Nuchtern et al.
ANNALS OF SURGERY (2012)
DNA methylation inhibitors in cancer: Recent and future approaches
Christina Gros et al.
BIOCHIMIE (2012)
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
G. Schleiermacher et al.
BRITISH JOURNAL OF CANCER (2012)
The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
Teeara Berry et al.
CANCER CELL (2012)
Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity
Kristopher R. Bosse et al.
CANCER RESEARCH (2012)
Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
Nai-Kong V. Cheung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
Shahab Asgharzadeh et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT Mutant
Mona Samy et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Neuroblastoma stage 4S: a multifocal stem-cell disease of the developing neural crest
Max M. van Noesel
LANCET ONCOLOGY (2012)
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Jan J. Molenaar et al.
NATURE (2012)
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
Sharon J. Diskin et al.
NATURE GENETICS (2012)
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
Jan J. Molenaar et al.
NATURE GENETICS (2012)
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma
E. E. Santo et al.
ONCOGENE (2012)
Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
Lukas C. Heukamp et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Neonatal neuroblastoma
Jonathan P. H. Fisher et al.
SEMINARS IN FETAL & NEONATAL MEDICINE (2012)
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
Chrystal U. Louis et al.
BLOOD (2011)
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study
Jane E. Minturn et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
The effect of P75 on Trk receptors in neuroblastomas
Ruth Ho et al.
CANCER LETTERS (2011)
Neuroblastoma epigenetics From candidate gene approaches to genome-wide screenings
Anneleen Decock et al.
EPIGENETICS (2011)
Prognostic Value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients With Metastatic Neuroblastoma Diagnosed Between Birth and 18 Months of Age
Denah R. Taggart et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Proteomics-based identification of spontaneous regression-associated proteins in neuroblastoma
Fang Yu et al.
JOURNAL OF PEDIATRIC SURGERY (2011)
Integrative genomics identifies LMO1 as a neuroblastoma oncogene
Kai Wang et al.
NATURE (2011)
Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci
Le B. Nguyen et al.
PLOS GENETICS (2011)
Assembling Neural Crest Regulatory Circuits into a Gene Regulatory Network
Paola Betancur et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 26 (2010)
Lestaurtinib Enhances the Antitumor Efficacy of Chemotherapy in Murine Xenograft Models of Neuroblastoma
Radhika Iyer et al.
CLINICAL CANCER RESEARCH (2010)
Epigenetic alterations in disseminated neuroblastoma tumour cells: influence of TMS1 gene hypermethylation in relapse risk in NB patients
E. Grau et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
Malcolm A. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma.
David L. Baker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Dependence receptors: a new paradigm in cell signaling and cancer therapy
D. Goldschneider et al.
ONCOGENE (2010)
Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma
Cinzia Lavarino et al.
BMC CANCER (2009)
On Trk-The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
Carol J. Thiele et al.
CLINICAL CANCER RESEARCH (2009)
Trk Receptor Expression and Inhibition in Neuroblastomas
Garrett M. Brodeur et al.
CLINICAL CANCER RESEARCH (2009)
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Tom Monclair et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
Rosalba Salcedo et al.
JOURNAL OF IMMUNOLOGY (2009)
Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
Mario Capasso et al.
NATURE GENETICS (2009)
Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo
Zaowen Chen et al.
NEOPLASIA (2009)
Localized infant neuroblastomas often show spontaneous regression: Results of the prospective trials NB95-S and NB97
Barbara Hero et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S
Jean Benard et al.
MOLECULAR ONCOLOGY (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Activating mutations in ALK provide a therapeutic target in neuroblastoma
Rani E. George et al.
NATURE (2008)
Oncogenic mutations of ALK kinase in neuroblastoma
Yuyan Chen et al.
NATURE (2008)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
Prevalence and functional consequence of PHOX2B mutations in neuroblastoma
E. H. Raabe et al.
ONCOGENE (2008)
Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression
Yael P. Mosse et al.
GENES CHROMOSOMES & CANCER (2007)
Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome
Qiwei Yang et al.
CLINICAL CANCER RESEARCH (2007)
Telomere length is a prognostic factor in neuroblastoma
Anat Ohali et al.
CANCER (2006)
High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: Long-term survival update
RE George et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma
Y. Ren et al.
ONCOGENE (2006)
Favorable outcome of triplold neuroblastomas: a contribution to the special oncogenesis of neuroblastoma
R Spitz et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1α in neuroblastoma cells
K Nakamura et al.
CANCER RESEARCH (2006)
Liver involvement in neuroblastoma: The memorial Sloan-Kettering experience supports treatment reduction in young patients
BH Kushner et al.
PEDIATRIC BLOOD & CANCER (2006)
Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
Katleen De Preter et al.
GENOME BIOLOGY (2006)
Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications
L Raffaghello et al.
ONCOGENE (2005)
Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study
T Oue et al.
JOURNAL OF PEDIATRIC SURGERY (2005)
Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma
D Trochet et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma
L Raffaghello et al.
NEOPLASIA (2004)
IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors:: Role for CD8+ T cells
R Salcedo et al.
JOURNAL OF IMMUNOLOGY (2004)
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: Critical role of DNAX accessory molecule-1-poliovirus receptor interaction
R Castriconi et al.
CANCER RESEARCH (2004)
Genetic epidemiology of neuroblastoma: A study of 426 cases at the Institut Gustave-Roussy in France
T Shojaei-Brosseau et al.
PEDIATRIC BLOOD & CANCER (2004)
Essential role of Gata transcription factors in sympathetic neuron development
K Tsarovina et al.
DEVELOPMENT (2004)
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma
A Tacconelli et al.
CANCER CELL (2004)
B- and T-cell markers in opsoclonus-myoclonus syndrome - Immunophenotyping of CSF lymphocytes
MR Pranzatelli et al.
NEUROLOGY (2004)
Germline PHOX2B mutation in hereditary neuroblastoma
YP Mosse et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Gene and protein expression profiling during differentiation of neuroblastoma cells triggered by 13-cis retinoic acid
Y Yuza et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2003)
Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma
M Krams et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
Production of macrophage migration inhibitory factor by human and murine neuroblastoma
Q Bin et al.
TUMOR BIOLOGY (2002)
Neuroblastoma screening at one year of age
FH Schilling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Screening of infants and mortality due to neuroblastoma
WG Woods et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours
D Astuti et al.
ONCOGENE (2001)
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies - A report from the Children's Cancer Group study
E Rudnick et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2001)
Telomerase activity as a prognostic factor in neuroblastomas
CJ Streutker et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2001)
Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus
NL Antunes et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2000)
Share Paper
